+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CRP, but not ESR, associated with disease severity and cardiovascular risk in patients with gout



CRP, but not ESR, associated with disease severity and cardiovascular risk in patients with gout








Accession: 020676775

Download citation: RISBibTeXText


Related references

Crystal-proven Gout and Characteristic Gout Severity Factors Are Associated with Cardiovascular Disease. Journal of Rheumatology 45(6): 858-863, 2018

When gout goes to the heart: does gout equal a cardiovascular disease risk factor?. Annals of the Rheumatic Diseases 74(4): 631-634, 2015

Nurse-led cardiovascular disease risk management intervention for patients with gout. European Journal of Cardiovascular Nursing 10(2): 94-100, 2011

Homocysteine, a marker of cardiovascular disease risk, is markedly elevated in patients with gout. Annals of the Rheumatic Diseases 72(3): 457, 2013

Patients with gout have short telomeres compared with healthy participants: association of telomere length with flare frequency and cardiovascular disease in gout. Annals of the Rheumatic Diseases 76(7): 1313-1319, 2017

Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease. Journal of Dermatology 40(11): 923-926, 2013

Effect of Urate-lowering Therapy on the Risk of Cardiovascular Disease and All-cause Mortality in Patients with Gout: A Case-matched Cohort Study. Journal of Rheumatology 42(9): 1694-1701, 2015

Association between mean platelet volume and severity of disease in patients with obstructive sleep apnea syndrome without risk factors for cardiovascular disease. Turk Kardiyoloji Dernegi Arsivi 41(1): 14-20, 2013

Major Cardiovascular Events in Patients with Gout and Associated Cardiovascular Disease or Heart Failure and Chronic Kidney Disease Initiating a Xanthine Oxidase Inhibitor. American Health and Drug Benefits 10(8): 393-401, 2017

Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis. Indian Dermatology Online Journal 6(5): 322-325, 2015

Gout is a risk factor for cardiovascular disease. Practitioner 251(1701): 25-28, 2007

Intermittent claudication in older patients: risk factors, cardiovascular comorbidity, and severity of peripheral arterial disease. Journal of the American Geriatrics Society 49(9): 1261-1262, 2001

Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?. Current Rheumatology Reports 12(2): 118-124, 2010

THU0503Major Cardiovascular Events in Patients with Recurrent Gout, Cardiovascular and Chronic Kidney Disease, Initiating on Allopurinol or Febuxostat. Annals of the Rheumatic Diseases 75(Suppl 2): 374.1-374, 2016

Cardiovascular Risk Stratification in Patients with Metabolic Syndrome Without Diabetes or Cardiovascular Disease: Usefulness of Metabolic Syndrome Severity Score. High Blood Pressure and Cardiovascular Prevention 24(3): 297-303, 2017